Vaxart, Inc. Research And Development Expense

• Vaxart, Inc. showed an increase of +171.6% in Research And Development Expense from 2024 to 2025.
• This data is from Vaxart, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
• XBRL data for this metric is available from 2009 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: $6.53 million | Q3 2010: $6.80 million | Q1 2011: $5.34 million | Q2 2011: $6.46 million | Q3 2011: $4.39 million | Q4 2011: $5.73 million | Q1 2012: $5.71 million | Q2 2012: $1.33 million | Q3 2012: $4.60 million | Q4 2012: $4.60 million | Q1 2013: $4.50 million | Q3 2013: $3.00 million | Q4 2013: $4.20 million | Q1 2014: $4.10 million | Q3 2014: $4.90 million | Q4 2014: $4.80 million | Q1 2015: $4.80 million | Q3 2015: $5.50 million | Q4 2015: $6.30 million | Q1 2016: $8.50 million | Q3 2016: $7.60 million | Q4 2016: $10.20 million | Q1 2017: $3.88 million | Q2 2017: $4.32 million | Q3 2017: $2.25 million | Q4 2017: $2.50 million | Q1 2018: $3.41 million | Q2 2018: $5.01 million | Q3 2018: $4.38 million | Q1 2019: $3.83 million | Q2 2019: $3.71 million | Q3 2019: $3.71 million | Q1 2020: $1.54 million | Q2 2020: $5.11 million | Q3 2020: $4.62 million | Q1 2021: $10.07 million | Q2 2021: $10.74 million | Q3 2021: $12.41 million | Q1 2022: $18.20 million | Q2 2022: $19.93 million | Q3 2022: $22.47 million | Q1 2023: $19.62 million | Q2 2023: $18.81 million | Q3 2023: $15.00 million | Q1 2024: $19.01 million | Q2 2024: $17.48 million | Q3 2024: $15.07 million | Q1 2025: $30.74 million | Q2 2025: $49.74 million | Q3 2025: $75.95 million.
• Over the full 19 years of available data (2009 to 2025), Vaxart, Inc.'s Research And Development Expense has grown by 1,122.4%.
• Historical annual values: Fiscal year 2025: $201.58 million | Fiscal year 2024: $74.21 million | Fiscal year 2023: $68.14 million | Fiscal year 2022: $81.05 million | Fiscal year 2021: $48.75 million | Fiscal year 2020: $19.86 million | Fiscal year 2019: $14.54 million | Fiscal year 2018: $17.28 million | Fiscal year 2017: $12.36 million | Fiscal year 2017: $28.30 million | Fiscal year 2016: $26.30 million | Fiscal year 2015: $19.80 million | Fiscal year 2014: $17.50 million | Fiscal year 2013: $19.90 million | Fiscal year 2012: $24.10 million | Fiscal year 2011: $17.77 million | Fiscal year 2011: $33.50 million | Fiscal year 2010: $26.08 million | Fiscal year 2009: $16.49 million.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026